Moreover, it is reported that EXT1 promoter hypermethylation was detected in many types of cancers, including non‐melanoma skin cancer and leukaemia, especially acute promyelocytic leukaemia and acute lymphoblastic leukaemia.21 Here, EXT1 is linked to leukemia.